WHO Under Siege By Private Sector, Group Asserts 13/03/2012 by Intellectual Property Watch Leave a Comment The World Health Organization is under siege by private sector forces using their financial leverage to gain undue influence in the financially beleaguered United Nations agency, a developing country-oriented group has said.
India Grants First Compulsory Licence, For Bayer Cancer Drug 12/03/2012 by Maricel Estavillo for Intellectual Property Watch 8 Comments In a move welcomed by many in the international community, India has granted an application, its first, from a homegrown generic drug maker to manufacture and sell a patented cancer drug under a compulsory licence.
WIPO Sets Record For International Patent Filings In 2011; LDCs Not A Factor 05/03/2012 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization today announced that it had set a new record for filings of patents at the international level in 2011, in what the UN agency attributed to a focus on innovation. Patents filed under the WIPO-managed Patent Cooperation Treaty shot up more than 10 per cent last year in the fastest growth since 2005, and a Chinese company took top honour for most filings.
Novartis Before India’s Supreme Court: What’s Really At Stake? 02/03/2012 by Rachel Marusak Hermann, Intellectual Property Watch 3 Comments As the Novartis Glivec patent case in India reaches the final phase of a long-running legal battle, there’s one point on which both the Swiss pharmaceutical company and its critics agree: the significance of this case goes far beyond the protection of a single medication.
The Pulse Of IP In International Pharma Today 24/02/2012 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment High-level policymakers, industry leaders, law professors and other stakeholders came together in Geneva recently to discuss the how the role of intellectual property is evolving when it comes to developing, protecting, and providing medicines.
WIPO Achieves Single Legal Text On Genetic Resources; Indigenous Peoples Back 23/02/2012 by Catherine Saez, Intellectual Property Watch 3 Comments After eight days of intensive drafting work, delegates at the World Intellectual Property Organization now have a text that will be submitted to the WIPO General Assemblies in September so that a diplomatic conference can be decided upon to finish negotiations on an international instrument protecting genetic resources from misappropriation.
Indigenous Peoples Walk Out Of WIPO Committee On Genetic Resources 22/02/2012 by Catherine Saez, Intellectual Property Watch 2 Comments The International Indigenous Forum, in an unprecedented collective move, decided yesterday to withdraw from the discussions of the WIPO Committee on Genetic Resources taking place from 14-22 February. The move calls into question the legitimacy of the negotiations.
WIPO Members Work Through Differences In Genetic Resources Document 19/02/2012 by Catherine Saez, Intellectual Property Watch 3 Comments The development of an international instrument on the protection of genetic resources continues to engage government delegates at the World Intellectual Property Organization. Sources have called the process constructive and meeting Chair Wayne McCook, the permanent representative of Jamaica, said delegations were very engaged in the exercise. But a sharp divide remains on several subjects.
WHO Group Keeps Lid On Bird Flu Lab Results – For Now 17/02/2012 by Intellectual Property Watch 1 Comment A group of public health experts gathered by the World Health Organization agreed today to continue a moratorium on research done on the H5N1 bird flu virus modified in a laboratory to be more transmissible between mammals. But they said research should continue on the naturally occurring version of the virus.
Public Health In 2012: A Busy Crossroads Of Partnership, Innovation, And Trade 17/02/2012 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment From advancing public-private partnerships and increasing international collaboration to promoting innovation in neglected therapy areas and developing new research and development models, policymakers have set a steady pace as they advance the 2012 global health agenda.